Bharath Holla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bharath Holla has a total of 712 co-authors. Here are the top co-authors by number of shared publications:
- Biju Viswanath
National Institute of Mental Health and Neuro Sciences
17 shared publications - Vivek Benegal
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, India
12 shared publications - Ganesan Venkatasubramanian
Translational Psychiatry Laboratory, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
11 shared publications Vivek Benegal
Department of Psychiatry National Institute of Mental Health and Neurosciences Bangalore India
10 shared publications- Hemant Bhargav
Intergrative Medicine Bengaluru Karnataka 560029 National Institute of Mental Health and Neurosciences (NIMHANS))
9 shared publications Jayant Mahadevan
Centre for Addiction Medicine, Department of Psychiatry Bengaluru Karnataka 560029 National Institute of Mental Health and Neurosciences (NIMHANS)
8 shared publications
Latest Publications
- 27 October 2026
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Cross‐Ancestry Polygenic Prediction of Bipolar Disorder and Obsessive‐Compulsive Disorder in India
Most genetic studies of psychiatric disorders have been conducted predominantly in populations of European ancestry, limiting evidence for the transferability of polygenic scores (PGS) to other populations. This cross‐sectional study evaluated the predictive performance of European‐derived PGS for bipolar disorder (BD) and obsessive‐compulsive disorder (OCD) in an Indian sample. Participants ( N = 2531) included individuals with BD ( N = 463), OCD ( N = 554), and controls ( N = 1514) recruited from hospital‐ and community‐based samples. Genotyping was performed using the Illumina Global Screening Array. PGS were derived from the summary statistics of European‐ancestry genome‐wide association studies using two Bayesian methods, PRS‐CS‐auto and SBayesRC. Principal component analyses demonstrated genetic overlap of the study population with other South Asian populations. BD PGS showed significant predictive performance, explaining approximately 6%–7% of liability‐scale variance with PGS‐only AUCs of ~0.71. OCD PGS showed lower but significant predictive performance, explaining ~2%–3% of variance with AUCs of approximately 0.59. Bayesian approaches showed better predictive performance than conventional clumping‐and‐thresholding. These findings demonstrate that European‐derived psychiatric PGS can retain predictive information in an Indian population, although performance differed between disorders. The application of Bayesian PGS methods in this Indian cohort supports their utility for cross‐ancestry prediction, while reinforcing the need for larger genomic studies in South Asian and other underrepresented populations.
- 27 October 2026
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Cross‐Ancestry Polygenic Prediction of Bipolar Disorder and Obsessive‐Compulsive Disorder in India
Most genetic studies of psychiatric disorders have been conducted predominantly in populations of European ancestry, limiting evidence for the transferability of polygenic scores (PGS) to other populations. This cross‐sectional study evaluated the predictive performance of European‐derived PGS for bipolar disorder (BD) and obsessive‐compulsive disorder (OCD) in an Indian sample. Participants ( N = 2531) included individuals with BD ( N = 463), OCD ( N = 554), and controls ( N = 1514) recruited from hospital‐ and community‐based samples. Genotyping was performed using the Illumina Global Screening Array. PGS were derived from the summary statistics of European‐ancestry genome‐wide association studies using two Bayesian methods, PRS‐CS‐auto and SBayesRC. Principal component analyses demonstrated genetic overlap of the study population with other South Asian populations. BD PGS showed significant predictive performance, explaining approximately 6%–7% of liability‐scale variance with PGS‐only AUCs of ~0.71. OCD PGS showed lower but significant predictive performance, explaining ~2%–3% of variance with AUCs of approximately 0.59. Bayesian approaches showed better predictive performance than conventional clumping‐and‐thresholding. These findings demonstrate that European‐derived psychiatric PGS can retain predictive information in an Indian population, although performance differed between disorders. The application of Bayesian PGS methods in this Indian cohort supports their utility for cross‐ancestry prediction, while reinforcing the need for larger genomic studies in South Asian and other underrepresented populations.
- Open Access
- 26 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 918
Tele-Adaptation and Feasibility of a Brief Yoga Therapy Module for Generalized Anxiety Disorder: A Pilot Study
Background Generalized Anxiety Disorder (GAD) is highly prevalent, but access barriers limit treatment uptake. We systematically tele-adapted a validated 90-minute yoga therapy module into a brief 30-minute format and evaluated its acceptability, feasibility, and preliminary clinical effects. Methods Using expert content validation (n = 10), we developed a 30-minute tele-yoga module comprising Sukshma Vyayama, Vibhagiya Pranayama (6:4:8:4 ratio), Chandra Anuloma Viloma (4:8 ratio), Nadishodhana Pranayama, Bhramari Pranayama, and Yoga Nidra. Twenty adults (18 to 55 years) diagnosed with GAD (GAD-7 score of 5 or higher), with or without comorbid neurotic disorder, on stable pharmacotherapy or drug-naive, received one in-person orientation followed by thrice-weekly live tele-yoga sessions and weekly yoga philosophy discussions over 8 weeks. Primary outcomes included feasibility metrics: Acceptability of Intervention Measure (AIM), Feasibility of Intervention Measure (FIM), Client Satisfaction Questionnaire (CSQ), attendance, dropout rate, and Yoga Performance Assessment (YPA). Secondary outcomes were GAD-7 and Pittsburgh Sleep Quality Index (PSQI) at baseline, 4 weeks, and 8 weeks. The Friedman test was used for repeated-measures analysis on completers (n = 17). Results Seventeen of 20 participants (85%) completed the intervention with over 80% attendance. Three withdrew for non-intervention reasons. All feasibility criteria were met: AIM 4.52 +/− 0.21, FIM 4.45 +/− 0.18, CSQ 30.05 +/− 1.14, YPA 30.11 +/− 1.36. GAD-7 scores decreased significantly from a median of 13.0 (IQR 11.0 to 15.0) at baseline to 7.0 (IQR 6.0 to 8.0) at 8 weeks (chi-square = 33.52, p < 0.001). PSQI improved from 12.0 (IQR 11.0 to 15.0) to 7.0 (IQR 4.0 to 7.0) (chi-square = 31.39, p < 0.001). No adverse events occurred. Conclusions This brief tele-adapted yoga module is feasible, acceptable, and shows promising preliminary effects on anxiety and sleep quality in GAD. Randomized controlled trials are warranted.
- 26 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 918
Open AccessTele-Adaptation and Feasibility of a Brief Yoga Therapy Module for Generalized Anxiety Disorder: A Pilot Study
Background Generalized Anxiety Disorder (GAD) is highly prevalent, but access barriers limit treatment uptake. We systematically tele-adapted a validated 90-minute yoga therapy module into a brief 30-minute format and evaluated its acceptability, feasibility, and preliminary clinical effects. Methods Using expert content validation (n = 10), we developed a 30-minute tele-yoga module comprising Sukshma Vyayama, Vibhagiya Pranayama (6:4:8:4 ratio), Chandra Anuloma Viloma (4:8 ratio), Nadishodhana Pranayama, Bhramari Pranayama, and Yoga Nidra. Twenty adults (18 to 55 years) diagnosed with GAD (GAD-7 score of 5 or higher), with or without comorbid neurotic disorder, on stable pharmacotherapy or drug-naive, received one in-person orientation followed by thrice-weekly live tele-yoga sessions and weekly yoga philosophy discussions over 8 weeks. Primary outcomes included feasibility metrics: Acceptability of Intervention Measure (AIM), Feasibility of Intervention Measure (FIM), Client Satisfaction Questionnaire (CSQ), attendance, dropout rate, and Yoga Performance Assessment (YPA). Secondary outcomes were GAD-7 and Pittsburgh Sleep Quality Index (PSQI) at baseline, 4 weeks, and 8 weeks. The Friedman test was used for repeated-measures analysis on completers (n = 17). Results Seventeen of 20 participants (85%) completed the intervention with over 80% attendance. Three withdrew for non-intervention reasons. All feasibility criteria were met: AIM 4.52 +/− 0.21, FIM 4.45 +/− 0.18, CSQ 30.05 +/− 1.14, YPA 30.11 +/− 1.36. GAD-7 scores decreased significantly from a median of 13.0 (IQR 11.0 to 15.0) at baseline to 7.0 (IQR 6.0 to 8.0) at 8 weeks (chi-square = 33.52, p < 0.001). PSQI improved from 12.0 (IQR 11.0 to 15.0) to 7.0 (IQR 4.0 to 7.0) (chi-square = 31.39, p < 0.001). No adverse events occurred. Conclusions This brief tele-adapted yoga module is feasible, acceptable, and shows promising preliminary effects on anxiety and sleep quality in GAD. Randomized controlled trials are warranted.
- Open Access
- 4 September 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 577
Effect of Add-on Integrated Yoga and Ayurveda Management on Clinical and Neurobiological Parameters in Multiple Sclerosis: A Randomized Controlled Trial Protocol
Background Multiple sclerosis (MS) is a progressive autoimmune neurodegenerative disorder characterized by inflammation, demyelination, and axonal damage. Current disease-modifying therapies demonstrate limited efficacy with substantial adverse effects. Ayurveda and yoga have demonstrated disease-modifying potential through anti-inflammatory, immunomodulatory, and neuroprotective mechanisms. Objective This study aims to evaluate the efficacy of a three-month Integrated Yoga and Ayurveda Management (IYAM) program as an adjunct to standard care in MS patients. Primary outcomes include clinical disability (EDSS), functional capacity (MSFC), quality of life (MSQOL-54), cognition (AVLT), and psychological parameters (HARS/HDRS). Secondary outcomes encompass neuroimaging (brain volume, connectivity), immune biomarkers (Th1/Th2/Th17/Treg cells, cytokines, telomere length), autonomic function (HRV), and gut microbiome composition. Methods In this assessor-blind randomized controlled superiority trial, 60 MS patients (McDonald criteria 2017, disease duration <2 years) will be recruited from tertiary care settings after informed consent. Participants will be randomly allocated (1:1) to IYAM (Ayurvedic Rasayanas: Lashuna 16 days, Bala 36 days, Shatavari 36 days and 2 days alotted for sadhyovirechana, plus yoga therapy) or standard care. A computer-generated randomization sequence was created using the REDCap randomization module. Group assignments were concealed until participant enrollment, ensuring allocation concealment, with blinded assessors. Assessments at baseline, 45 days and three months include clinical scales, neuropsychological testing, 3 T MRI, immunophenotyping, and microbiome analysis. Intent-to-treat analysis with mixed repeated measures ANOVA. Expected Outcomes Significant improvements in disability, cognition, and quality of life are anticipated in IYAM group, mediated through neuroinflammatory modulation, enhanced neuroprotection, and favorable gut microbiome alterations. Trial Registration Clinical Trials Registry-India (CTRI/2024/12/078605); date of registration: 26 December 2024; dates of clinical trial: January 2025 to December 2027. Protocol Version Version 1.0, October 2025.
- 4 September 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 577
Open AccessEffect of Add-on Integrated Yoga and Ayurveda Management on Clinical and Neurobiological Parameters in Multiple Sclerosis: A Randomized Controlled Trial Protocol
Background Multiple sclerosis (MS) is a progressive autoimmune neurodegenerative disorder characterized by inflammation, demyelination, and axonal damage. Current disease-modifying therapies demonstrate limited efficacy with substantial adverse effects. Ayurveda and yoga have demonstrated disease-modifying potential through anti-inflammatory, immunomodulatory, and neuroprotective mechanisms. Objective This study aims to evaluate the efficacy of a three-month Integrated Yoga and Ayurveda Management (IYAM) program as an adjunct to standard care in MS patients. Primary outcomes include clinical disability (EDSS), functional capacity (MSFC), quality of life (MSQOL-54), cognition (AVLT), and psychological parameters (HARS/HDRS). Secondary outcomes encompass neuroimaging (brain volume, connectivity), immune biomarkers (Th1/Th2/Th17/Treg cells, cytokines, telomere length), autonomic function (HRV), and gut microbiome composition. Methods In this assessor-blind randomized controlled superiority trial, 60 MS patients (McDonald criteria 2017, disease duration <2 years) will be recruited from tertiary care settings after informed consent. Participants will be randomly allocated (1:1) to IYAM (Ayurvedic Rasayanas: Lashuna 16 days, Bala 36 days, Shatavari 36 days and 2 days alotted for sadhyovirechana, plus yoga therapy) or standard care. A computer-generated randomization sequence was created using the REDCap randomization module. Group assignments were concealed until participant enrollment, ensuring allocation concealment, with blinded assessors. Assessments at baseline, 45 days and three months include clinical scales, neuropsychological testing, 3 T MRI, immunophenotyping, and microbiome analysis. Intent-to-treat analysis with mixed repeated measures ANOVA. Expected Outcomes Significant improvements in disability, cognition, and quality of life are anticipated in IYAM group, mediated through neuroinflammatory modulation, enhanced neuroprotection, and favorable gut microbiome alterations. Trial Registration Clinical Trials Registry-India (CTRI/2024/12/078605); date of registration: 26 December 2024; dates of clinical trial: January 2025 to December 2027. Protocol Version Version 1.0, October 2025.
- Open Access
- 11 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Efficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide, and 7-day point-prevalence abstinence (7PPA). In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on an as-neededs basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8 th week. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 11 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Open AccessEfficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide, and 7-day point-prevalence abstinence (7PPA). In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on an as-neededs basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8 th week. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 9 August 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 124, 105116
For better and for worse: Evidence of differential susceptibility to environmental adversity in youth substance use from the cVEDA cohort
- 9 August 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 124, 105116
For better and for worse: Evidence of differential susceptibility to environmental adversity in youth substance use from the cVEDA cohort
- Open Access
- 5 June 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Efficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide. In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on sos basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8thweek. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 5 June 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Open AccessEfficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide. In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on sos basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8thweek. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- Open Access
- 29 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Plasma Glial Fibrillary Acidic Protein (GFAP) shows age-dependent associations with externalizing psychopathology and atypical brain connectivity
Externalizing disorders are common neurodevelopmental conditions, yet their underlying biology is not fully understood. Integrating peripheral biomarkers with brain imaging offers a powerful approach to elucidate the pathophysiology of these disorders. This study aimed to investigate the association between indicators of glial activation (glial fibrillary acidic protein; GFAP) and axonal injury (neurofilament light chain; NfL) in plasma with functional brain connectivity, and externalizing psychopathology (EXT) in a neurodevelopmental cohort. Towards this, a cross-sectional study was conducted with 144 participants selected from the Indian cVEDA cohort and balanced into EXT and healthy control (HC) groups using Mahalanobis distance matching. Plasma GFAP and NfL were quantified using Simoa technology. Resting-state fMRI data were used to generate between-network connectivity deviation scores via normative modelling. We used Gamma General Linear Models (Gamma GLMs) to test for an age-by-EXT interaction on GFAP/ NfL levels and sparse partial least squares (sPLS) regression to identify connectivity features that correlated with them. We found a significant age-by-EXT interaction for GFAP (p = 0.002), where EXT was associated with higher GFAP levels only in younger participants (<14 years). No significant effects were found for NfL. The sPLS analysis identified a significant five-feature brain connectivity signature that correlated with GFAP levels. This pattern was characterized by atypically strong connectivity between sensorimotor-limbic and attention-default mode networks, and weaker-than-expected connectivity within the default mode network. In conclusion, our findings identify a strong association between plasma GFAP and EXT in youth in an age dependent manner, suggesting a key role for glial activation in the early pathophysiology of these disorders. This process is linked to a specific, multivariate pattern of brain dysconnectivity, providing a potential neurobiological signature that warrants further investigation.
- 29 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessPlasma Glial Fibrillary Acidic Protein (GFAP) shows age-dependent associations with externalizing psychopathology and atypical brain connectivity
Externalizing disorders are common neurodevelopmental conditions, yet their underlying biology is not fully understood. Integrating peripheral biomarkers with brain imaging offers a powerful approach to elucidate the pathophysiology of these disorders. This study aimed to investigate the association between indicators of glial activation (glial fibrillary acidic protein; GFAP) and axonal injury (neurofilament light chain; NfL) in plasma with functional brain connectivity, and externalizing psychopathology (EXT) in a neurodevelopmental cohort. Towards this, a cross-sectional study was conducted with 144 participants selected from the Indian cVEDA cohort and balanced into EXT and healthy control (HC) groups using Mahalanobis distance matching. Plasma GFAP and NfL were quantified using Simoa technology. Resting-state fMRI data were used to generate between-network connectivity deviation scores via normative modelling. We used Gamma General Linear Models (Gamma GLMs) to test for an age-by-EXT interaction on GFAP/ NfL levels and sparse partial least squares (sPLS) regression to identify connectivity features that correlated with them. We found a significant age-by-EXT interaction for GFAP (p = 0.002), where EXT was associated with higher GFAP levels only in younger participants (<14 years). No significant effects were found for NfL. The sPLS analysis identified a significant five-feature brain connectivity signature that correlated with GFAP levels. This pattern was characterized by atypically strong connectivity between sensorimotor-limbic and attention-default mode networks, and weaker-than-expected connectivity within the default mode network. In conclusion, our findings identify a strong association between plasma GFAP and EXT in youth in an age dependent manner, suggesting a key role for glial activation in the early pathophysiology of these disorders. This process is linked to a specific, multivariate pattern of brain dysconnectivity, providing a potential neurobiological signature that warrants further investigation.
- Open Access
- 8 April 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 208
Development, Validation and Feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for Children with ADHD: A Cross-Sectional Pilot Study
Background Motor dysregulation occurs in 30–50% of children with Attention-Deficit/Hyperactivity Disorder (ADHD), reflecting impairments in neuromuscular control linked to fronto-striato-cerebellar circuitry. Conventional motor batteries may not adequately capture ADHD-specific regulatory deficits. This study aimed to develop, validate, and evaluate the feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for children with ADHD. Methods A cross-sectional pilot study was conducted at a tertiary psychiatric centre in India. Seven motor domains implicated in ADHD were identified through a literature review and mapped to yoga-based tasks by subject experts. Content validity was assessed using Lawshe’s Content Validity Ratio (CVR). Using purposive sampling, 24 children aged 8–15 years (12 ADHD, 12 typically developing controls) underwent Y-MAT assessment. ADHD symptom severity and adaptive functioning were evaluated using the ADHD Rating Scale (ADHD-RS) and Vineland Social Maturity Scale. Video recordings were independently scored by two blinded raters. An AI prototype employing pose estimation (Google MediaPipe and YOLOv8) was piloted on selected domains. Results Five yoga-based tasks achieved CVR = 1.00 and constituted the final Y-MAT. Feasibility metrics demonstrated high acceptability, demand, implementation fidelity, and practicality. Children with ADHD scored significantly lower than controls (human rating: 10.8 ± 7.1 vs 23.8 ± 4.0, p < 0.001; AI scoring: 12.5 ± 5.9 vs 19.1 ± 2.2, p = 0.002). Inter-rater reliability ranged from Kendall’s W = 0.23 to 0.55. Y-MAT total scores showed significant negative correlations with ADHD symptom severity. ROC analysis demonstrated excellent discriminatory validity (AUC = 0.910 human scoring; AUC = 0.896 AI scoring). Conclusions Y-MAT demonstrates preliminary validity and strong feasibility as a culturally grounded motor regulation assessment for children with ADHD. The AI prototype provides proof of concept for objective, scalable screening. Larger multi-centre studies are needed to establish psychometric robustness and normative thresholds.
- 8 April 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 208
Open AccessDevelopment, Validation and Feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for Children with ADHD: A Cross-Sectional Pilot Study
Background Motor dysregulation occurs in 30–50% of children with Attention-Deficit/Hyperactivity Disorder (ADHD), reflecting impairments in neuromuscular control linked to fronto-striato-cerebellar circuitry. Conventional motor batteries may not adequately capture ADHD-specific regulatory deficits. This study aimed to develop, validate, and evaluate the feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for children with ADHD. Methods A cross-sectional pilot study was conducted at a tertiary psychiatric centre in India. Seven motor domains implicated in ADHD were identified through a literature review and mapped to yoga-based tasks by subject experts. Content validity was assessed using Lawshe’s Content Validity Ratio (CVR). Using purposive sampling, 24 children aged 8–15 years (12 ADHD, 12 typically developing controls) underwent Y-MAT assessment. ADHD symptom severity and adaptive functioning were evaluated using the ADHD Rating Scale (ADHD-RS) and Vineland Social Maturity Scale. Video recordings were independently scored by two blinded raters. An AI prototype employing pose estimation (Google MediaPipe and YOLOv8) was piloted on selected domains. Results Five yoga-based tasks achieved CVR = 1.00 and constituted the final Y-MAT. Feasibility metrics demonstrated high acceptability, demand, implementation fidelity, and practicality. Children with ADHD scored significantly lower than controls (human rating: 10.8 ± 7.1 vs 23.8 ± 4.0, p < 0.001; AI scoring: 12.5 ± 5.9 vs 19.1 ± 2.2, p = 0.002). Inter-rater reliability ranged from Kendall’s W = 0.23 to 0.55. Y-MAT total scores showed significant negative correlations with ADHD symptom severity. ROC analysis demonstrated excellent discriminatory validity (AUC = 0.910 human scoring; AUC = 0.896 AI scoring). Conclusions Y-MAT demonstrates preliminary validity and strong feasibility as a culturally grounded motor regulation assessment for children with ADHD. The AI prototype provides proof of concept for objective, scalable screening. Larger multi-centre studies are needed to establish psychometric robustness and normative thresholds.
- Top Cited PapersOpen Access
- 16 January 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 10, 669
The Brief Prakriti Inventory: Latent structure, reliability, and validity
Background Ayurveda, the traditional Indian medicine system, conceptualizes individual personality (Prakriti) through three dimensions, Vata, Pitta, and Kapha, based on physical, physiological, and psychological traits. Existing tools for Prakriti assessment often lack robust psychometric validation and accessibility. We developed and validated the Brief-Prakriti Inventory (BPI), a 21-item self-report instrument for assessing traditional Indian personality concepts. Methods An initial 30-item pool was derived from classical Ayurvedic texts and contemporary literature, covering three domains. Following pilot testing and psychometric screening, 21 items were retained. Items used nominal response formats, each mapped to a dosha, with randomized option order via REDCap. Psychometric evaluation employed Multiple Correspondence Analysis (MCA), Latent Class Analysis (LCA), and Item Response Theory (IRT) in a community sample (N = 1857). Validity was assessed via test–retest reliability, convergent validity with traditional AYUsoft assessments, and divergent validity using Western personality traits (Mini-IPIP). Results MCA revealed distinct dosha-aligned item clustering, particularly among participants with dominant dosha profiles (Figure 1). LCA supported a three-class model (dominant-only: entropy R2 = 0.96) (Figure 2, Supplementary Figure 1). IRT analyses showed strong fit (CFI = 0.967, RMSEA = 0.023) and good reliability (Vata = 0.87, Pitta = 0.75, Kapha = 0.87) (Figure 3). Psychological items showed highest discrimination; physiological items displayed higher difficulty thresholds. Test–retest reliability was high (ICCs 0.83–0.90). BPI subscales correlated strongly with traditional assessments (r = 0.78–0.84) (Supplementary Figure 2) but minimally with Western personality traits (Figure 4), supporting construct distinctiveness. Conclusions The BPI is a brief, reliable, psychometrically validated self-report tool that captures latent dosha typology consistent with Ayurvedic theory. By grouping individuals into Prakriti-based clusters, the BPI will enable biological phenotyping of dosha-linked variability and support personalized, culturally contextualized interventions in integrative and mental health care.
- 16 January 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 10, 669
Top Cited PapersOpen AccessThe Brief Prakriti Inventory: Latent structure, reliability, and validity
Background Ayurveda, the traditional Indian medicine system, conceptualizes individual personality (Prakriti) through three dimensions, Vata, Pitta, and Kapha, based on physical, physiological, and psychological traits. Existing tools for Prakriti assessment often lack robust psychometric validation and accessibility. We developed and validated the Brief-Prakriti Inventory (BPI), a 21-item self-report instrument for assessing traditional Indian personality concepts. Methods An initial 30-item pool was derived from classical Ayurvedic texts and contemporary literature, covering three domains. Following pilot testing and psychometric screening, 21 items were retained. Items used nominal response formats, each mapped to a dosha, with randomized option order via REDCap. Psychometric evaluation employed Multiple Correspondence Analysis (MCA), Latent Class Analysis (LCA), and Item Response Theory (IRT) in a community sample (N = 1857). Validity was assessed via test–retest reliability, convergent validity with traditional AYUsoft assessments, and divergent validity using Western personality traits (Mini-IPIP). Results MCA revealed distinct dosha-aligned item clustering, particularly among participants with dominant dosha profiles (Figure 1). LCA supported a three-class model (dominant-only: entropy R2 = 0.96) (Figure 2, Supplementary Figure 1). IRT analyses showed strong fit (CFI = 0.967, RMSEA = 0.023) and good reliability (Vata = 0.87, Pitta = 0.75, Kapha = 0.87) (Figure 3). Psychological items showed highest discrimination; physiological items displayed higher difficulty thresholds. Test–retest reliability was high (ICCs 0.83–0.90). BPI subscales correlated strongly with traditional assessments (r = 0.78–0.84) (Supplementary Figure 2) but minimally with Western personality traits (Figure 4), supporting construct distinctiveness. Conclusions The BPI is a brief, reliable, psychometrically validated self-report tool that captures latent dosha typology consistent with Ayurvedic theory. By grouping individuals into Prakriti-based clusters, the BPI will enable biological phenotyping of dosha-linked variability and support personalized, culturally contextualized interventions in integrative and mental health care.